Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation
Kim Newton
Cold Spring Harbor Perspectives in Biology (2019) Vol. 12, Iss. 3, pp. a036368-a036368
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression
Júlia Canet-Pons, Nesli-Ece Şen, Aleksandar Arsović, et al.
Neurobiology of Disease (2021) Vol. 152, pp. 105289-105289
Open Access | Times Cited: 34
Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
Shang Li, Lailiang Qu, Xiaobing Wang, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107979-107979
Closed Access | Times Cited: 33
Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases
Rohan Gupta, Kumari Smita, Rahul Tripathi, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101855-101855
Closed Access | Times Cited: 14
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
Kunyu Shi, Jifa Zhang, Enda Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 14971-14999
Closed Access | Times Cited: 21
RIP1 post-translational modifications
Eugene Varfolomeev, Domagoj Vucic
Biochemical Journal (2022) Vol. 479, Iss. 9, pp. 929-951
Closed Access | Times Cited: 20
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Wenli Zhao, Yue Liu, Lijuan Xu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 12, pp. 1697-1713
Closed Access | Times Cited: 19
Blockade of IKK signaling induces RIPK1-independent apoptosis in human macrophages
Neha M. Nataraj, Reyna Garcia Sillas, Beatrice Herrmann, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012469-e1012469
Open Access | Times Cited: 4
A bacterial network of T3SS effectors counteracts host pro-inflammatory responses and cell death to promote infection
Hui Wen Yeap, Ghin Ray Goh, Safwah Nasuha Rosli, et al.
The EMBO Journal (2025)
Open Access
The Role of Post-Translational Modifications in Necroptosis
Hao Xiao, Zang Chao Han, Min Xu, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 549-549
Open Access
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 2, pp. 101-124
Closed Access | Times Cited: 10
Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease
Satyam Pati, Avtar Singh Gautam, Mangaldeep Dey, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103750-103750
Closed Access | Times Cited: 10
cIAPs control RIPK1 kinase activity‐dependent and ‐independent cell death and tissue inflammation
Fabian Schorn, J Paul Werthenbach, M. Hoffmann, et al.
The EMBO Journal (2023) Vol. 42, Iss. 22
Open Access | Times Cited: 10
Caspase-8 inhibition improves the outcome of bacterial infections in mice by promoting neutrophil activation
Germana Lentini, Agata Famà, Giuseppe Valerio De Gaetano, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101098-101098
Open Access | Times Cited: 9
Inhibition of cIAP1/2 reduces RIPK1 phosphorylation in pulmonary endothelial cells and alleviate sepsis-induced lung injury and inflammatory response
Xiaoyu Liu, Yan Li, Weijian Zhang, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 841-850
Closed Access | Times Cited: 3
The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1
Miaomiao Yang, Yujie Wei, Xin He, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
Qiuyun Xu, Xiaorong Zhou, Warren Strober, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1725-1725
Open Access | Times Cited: 22
RIPK1-Associated Inborn Errors of Innate Immunity
Jiahui Zhang, Taijie Jin, Ivona Aksentijevich, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
A phase I, randomized, ascending‐dose study to assess safety, pharmacokinetics, and activity of GDC‐8264, a RIP1 inhibitor, in healthy volunteers
Nicholas S. Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1997-2009
Open Access | Times Cited: 8
Deubiquitinases in cell death and inflammation
Kim Newton, Alexander D. Gitlin
Biochemical Journal (2022) Vol. 479, Iss. 10, pp. 1103-1119
Open Access | Times Cited: 13
TAK1 Improves Cognitive Function via Suppressing RIPK1-Driven Neuronal Apoptosis and Necroptosis in Rats with Chronic Hypertension
Jing Yang, Pei Sun, Xiangming Xu, et al.
Aging and Disease (2023) Vol. 14, Iss. 5, pp. 1799-1799
Open Access | Times Cited: 7
Multi‐Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation
Liting Wang, Qing Shen, Hongze Liao, et al.
Advanced Science (2021) Vol. 8, Iss. 11
Open Access | Times Cited: 17
Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways
Nathan P. Manes, Aleksandra Nita‐Lazar
mSystems (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 16
Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel?
Jacqueline Williams, James C. Bonner, Karen V. Kibler, et al.
Advances in experimental medicine and biology (2024), pp. 125-137
Closed Access | Times Cited: 2
RIPK1: A rising star in inflammatory and neoplastic skin diseases
Liping Jin, Panpan Liu, Mingzhu Yin, et al.
Journal of Dermatological Science (2020) Vol. 99, Iss. 3, pp. 146-151
Closed Access | Times Cited: 18
Protective role of baicalin in the dynamic progression of lung injury to idiopathic pulmonary fibrosis: A meta-analysis
Jiajie Jiang, Te-chan Kao, Sihan Hu, et al.
Phytomedicine (2023) Vol. 114, pp. 154777-154777
Closed Access | Times Cited: 5

Scroll to top